Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...
Depression makes the brain more sensitive to negative experiences and less responsive to positive ones, linked to specific brain circuits in the amygdala.